Find Research Outputs

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Author

  • Joseph Patrick McEvoy
2020

A Modified Delphi Consensus Study of the Screening, Diagnosis, and Treatment of Tardive Dyskinesia

Caroff, S. N., Citrome, L., Meyer, J., Sajatovic, M., Goldberg, J. F., Jain, R., Lundt, L., Lindenmayer, J. P., McEvoy, J. P., McIntyre, R. S., Tohen, M. & Ketter, T. A., Jan 28 2020, In : The Journal of clinical psychiatry. 81, 2

Research output: Contribution to journalArticle

A single assessment with the Brief Adherence Rating Scale (BARS) discriminates responders to long-acting injectable antipsychotic treatment in patients with schizophrenia

Nakonezny, P. A., Lindow, J. C., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A. & Byerly, M. J., Jan 1 2020, (Accepted/In press) In : Schizophrenia Research.

Research output: Contribution to journalArticle

The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures

Kraus, M. S., Gold, J. M., Barch, D. M., Walker, T. M., Chun, C. A., Buchanan, R. W., Csernansky, J. G., Goff, D. C., Green, M. F., Jarskog, L. F., Javitt, D. C., Kimhy, D., Lieberman, J. A., McEvoy, J. P., Mesholam-Gately, R. I., Seidman, L. J., Ball, M. P., Kern, R. S., McMahon, R. P., Robinson, J. & 2 others, Marder, S. R. & Keefe, R. S. E., Mar 2020, In : Schizophrenia Research: Cognition. 19, 100161.

Research output: Contribution to journalArticle

Open Access
2019

34 Long-Term Deutetrabenazine Treatment Response in Tardive Dyskinesia by Concomitant Dopamine-Receptor Antagonists and Baseline Comorbidities

Anderson, K. E., Stamler, D., Davis, M. D., Hauser, R. A., Jarskog, L. F., Jimenez-Shahed, J., Kumar, R., Ochudlo, S., McEvoy, J. P. & Fernandez, H. H., Feb 1 2019, In : CNS spectrums. 24, 1, 1 p.

Research output: Contribution to journalArticle

Open Access

35 Long-term Improvements in Site-Rated Outcomes with Deutetrabenazine Treatment in Patients with Tardive Dyskinesia

Anderson, K. E., Stamler, D., Davis, M. D., Gross, N., Hauser, R. A., Jarskog, L. F., Jimenez-Shahed, J., Kumar, R., Ochudlo, S., McEvoy, J. P. & Fernandez, H. H., Feb 1 2019, In : CNS spectrums. 24, 1, p. 193-194 2 p.

Research output: Contribution to journalArticle

Open Access

A commentary on the efficacy of olanzapine for the treatment of schizophrenia: The past, present, and future

Citrome, L., McEvoy, J. P., Todtenkopf, M. S., McDonnell, D. & Weiden, P. J., Jan 1 2019, In : Neuropsychiatric Disease and Treatment. 15, p. 2559-2569 11 p.

Research output: Contribution to journalReview article

Open Access
1 Scopus citations

Characterizing treatment effects of valbenazine for tardive dyskinesia: Additional results from the KINECT 3 study

Correll, C. U., Cutler, A. J., Kane, J. M., McEvoy, J. P., Liang, G. S. & O'Brien, C. F., Jan 2019, In : Journal of Clinical Psychiatry. 80, 1

Research output: Contribution to journalArticle

2 Scopus citations

Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia

McEvoy, J., Gandhi, S. K., Rizio, A. A., Maher, S., Kosinski, M., Bjorner, J. B. & Carroll, B., Dec 1 2019, In : Quality of Life Research. 28, 12, p. 3303-3312 10 p.

Research output: Contribution to journalArticle

Open Access

FDA-Approved Medications to Treat Tardive Dyskinesia

McEvoy, J. P., Dec 17 2019, In : The Journal of clinical psychiatry. 81, 1

Research output: Contribution to journalArticle

Heterogeneity of treatment effects of long-acting injectable antipsychotic medications

Stroup, T. S., Bareis, N. A., Rosenheck, R. A., Swartz, M. S. & McEvoy, J. P., Jan 2019, In : Journal of Clinical Psychiatry. 80, 1

Research output: Contribution to journalArticle

1 Scopus citations

The burden of tardive dyskinesia secondary to antipsychotic medication use among patients with mental disorders

McEvoy, J., Park, T., Schilling, T., Terasawa, E., Ayyagari, R. & Carroll, B., Jul 3 2019, In : Current Medical Research and Opinion. 35, 7, p. 1205-1214 10 p.

Research output: Contribution to journalArticle

1 Scopus citations
2018

Adjunct Aripiprazole Reduces Prolactin and Prolactin-Related Adverse Effects in Premenopausal Women with Psychosis: Results from the DAAMSEL Clinical Trial

Kelly, D. L., Powell, M. M., Wehring, H. J., Sayer, M. A., Kearns, A. M., Hackman, A. L., Buchanan, R. W., Nichols, R. B., Adams, H. A., Richardson, C. M., Vyas, G., McMahon, R. P., Earl, A. K., Sullivan, K. M., Liu, F., Luttrell, S. E., Dickerson, F. B., Feldman, S. M., Narang, S., Koola, M. M. & 3 others, Buckley, P. F., Rachbeisel, J. A. & McEvoy, J. P., Aug 1 2018, In : Journal of Clinical Psychopharmacology. 38, 4, p. 317-326 10 p.

Research output: Contribution to journalArticle

3 Scopus citations

Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels

Wehring, H. J., Elsobky, T., McEvoy, J. P., Vyas, G., Richardson, C. M., McMahon, R. P., DiPaula, B. A., Liu, F., Sullivan, K., Buchanan, R. W., Feldman, S., McMahon, E. M. & Kelly, D. L., Mar 1 2018, In : Psychiatric Quarterly. 89, 1, p. 73-80 8 p.

Research output: Contribution to journalArticle

6 Scopus citations

Evidence-Based Strategies for Managing Tardive Dyskinesia

McEvoy, J. P., Jan 1 2018, In : The Journal of clinical psychiatry. 79, 1

Research output: Contribution to journalArticle

9 Scopus citations

Revisiting the abnormal involuntary movement scale: Proceedings from the tardive dyskinesia assessment workshop

Kane, J. M., Correll, C. U., Nierenberg, A. A., Caroff, S. N., Sajatovic, M., Cutler, A. J., McEvoy, J. P. & Stacy, M., May 1 2018, In : Journal of Clinical Psychiatry. 79, 3, 17cs11959.

Research output: Contribution to journalArticle

7 Scopus citations

What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options

Manning, J. S. & McEvoy, J. P., Jan 1 2018, In : The Journal of clinical psychiatry. 79, 1

Research output: Contribution to journalArticle

1 Scopus citations
2017

Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial

Anderson, K. E., Stamler, D., Davis, M. D., Factor, S. A., Hauser, R. A., Isojärvi, J., Jarskog, L. F., Jimenez-Shahed, J., Kumar, R., McEvoy, J. P., Ochudlo, S., Ondo, W. G. & Fernandez, H. H., Aug 2017, In : The Lancet Psychiatry. 4, 8, p. 595-604 10 p.

Research output: Contribution to journalArticle

70 Scopus citations

Durability of therapeutic response with long-term aripiprazole lauroxil treatment following successful resolution of an acute episode of Schizophrenia

McEvoy, J. P., Risinger, R., Mykhnyak, S., Du, Y., Liu, C. C., Stanford, A. D. & Weiden, P. J., Sep 1 2017, In : Journal of Clinical Psychiatry. 78, 8, p. 1103-1109 7 p.

Research output: Contribution to journalArticle

5 Scopus citations

Prioritizing Harm

Moyer, K. H., McEvoy, J. P., Mabe, P. A., Buchanan, E., Venkatesan, A. & Buckley, P. F., Jan 2 2017, In : Journal of Personality Assessment. 99, 1, p. 78-82 5 p.

Research output: Contribution to journalArticle

2 Scopus citations

What's new in our understanding of schizophrenia

McEvoy, J. P., Feb 2017, In : Psychiatric Times. 34, 2

Research output: Contribution to journalArticle

2016

A guide to the management of clozapine-related tolerability and safety concerns

Citrome, L., McEvoy, J. P. & Saklad, S. R., Sep 1 2016, In : Clinical Schizophrenia and Related Psychoses. 10, 3, p. 163-177D

Research output: Contribution to journalReview article

25 Scopus citations

Brexpiprazole for the treatment of schizophrenia: A review of this novel serotonin-dopamine activity modulator

McEvoy, J. P. & Citrome, L., Dec 1 2016, In : Clinical Schizophrenia and Related Psychoses. 9, 4, p. 177-186 10 p.

Research output: Contribution to journalReview article

13 Scopus citations

Cost-effectiveness of long-acting injectable paliperidone palmitate versus haloperidol decanoate in maintenance treatment of schizophrenia

Rosenheck, R. A., Leslie, D. L., Sint, K. J., Lin, H., Li, Y., McEvoy, J. P., Byerly, M. J., Hamer, R. M., Swartz, M. S. & Stroup, T. S., Oct 1 2016, In : Psychiatric Services. 67, 10, p. 1124-1130 7 p.

Research output: Contribution to journalArticle

8 Scopus citations

Placebo controls in clinical trials: concerns about use in relapse prevention studies in schizophrenia

Emsley, R., Fleischhacker, W. W., Galderisi, S., Halpern, L. J., McEvoy, J. P. & Schooler, N. R., Sep 9 2016, In : BMJ (Clinical research ed.). 354, p. i4728

Research output: Contribution to journalArticle

2 Scopus citations

The RAISE connection program: Psychopharmacological treatment of people with a first episode of schizophrenia

Kreyenbuhl, J. A., Medoff, D. R., McEvoy, J. P., Smith, T. E., Hackman, A. L., Nossel, I. R., Dixon, L. B., Essock, S. M. & Buchanan, R. W., Dec 1 2016, In : Psychiatric Services. 67, 12, p. 1300-1306 7 p.

Research output: Contribution to journalArticle

6 Scopus citations

To the Editor

McEvoy, J. P., Oct 1 2016, In : JAMA Psychiatry. 73, 10, p. 1097-1098 2 p.

Research output: Contribution to journalLetter

2 Scopus citations